Basf Se vs Joint Controller Of Patents And Designs … on 7 March, 2025

0
37

Calcutta High Court

Basf Se vs Joint Controller Of Patents And Designs … on 7 March, 2025

Author: Ravi Krishan Kapur

Bench: Ravi Krishan Kapur

                      IN THE HIGH COURT AT CALCUTTA
                                ORIGINAL SIDE
                    (Intellectual Property Rights Division)

BEFORE:
The Hon'ble Justice Ravi Krishan Kapur

                               IPDPTA/5/2024

                           BASF SE
                              VS
       JOINT CONTROLLER OF PATENTS AND DESIGNS AND ORS

For the appellant                     : Ms. Archana Shankar, Adv.
                                        Mr. Devindra Rawat, Adv.
                                        Ms .Mini Agarwal, Adv.

For the respondent no.3               : Mr .Arkaprava Sen, Adv.
                                        Mr. Sayantan Kar, Adv.

For the respondent no.4               : Mr. Subhatosh Majumdar, Adv.
                                        Mr. K.K. Pandey, Adv.
                                        Ms. Mitul Dasgupta, Adv.
                                        Ms. Amrita Majumdar, Adv.
                                        Ms. Pooja Sett, Adv

Judgment on                           : 07.03.2025


RAVI KRISHAN KAPUR, J.:

1. This appeal has been filed under section 117A of the Indian Patents Act,

1970 challenging an order dated 4 March 2024 rejecting Patent

Application No.4842/KOLNP/2007 titled ‘CRYSTALLINE MODIFICATIONS

TO PYRACLOSTROBIN’.

2. Briefly, the subject invention relates to a new polymorphic form (Form IV

modification) of pyraclostrobin and the process for preparing the same.

The polymorphic form has been characterized and defined by its unique

X-Ray powder diffraction characteristics. The invention also claimed a

process for preparing the crystalline modification IV of pyraclostrobin. It is

submitted that there has been undue, inordinate and unexplained delay
2

in the disposal of the subject application which renders nugatory the

purpose and object of the Act. It is urged that only one year of the term of

the patent remains out of the stipulated 20 year period. The subject

application was filed on 12 December 2007 and has been rejected after a

period of approximately 18 years. The term of the subject application is

due to expire on 19 June 2026. Thus, the impugned order is liable to be

set aside on the ground of delay, being in violation of principles of natural

justice.

3. Upon filing of the subject application, three pre-grant oppositions under

section 25(1) of the Act were filed by the respondent nos.2, 3 and 4

respectively. The last of such oppositions was filed by the respondent no.4

on 1 March 2024.

4. On merits, it is contended that the impugned order is erroneous and the

test to determine the aspect of obviousness has been incorrectly applied.

In passing the impugned order, the respondent no.1 has failed to

appreciate the technical advantage of the subject invention and has

ignored the affidavit filed by the expert and relied on by the appellant.

5. On behalf of the respondent authorities, it is fairly submitted that there is

no justification in the delay in disposing of the application. Such an

approach by the respondent authorities is destructive of the very purpose

and object of having an invention patented and cannot be justified.

6. On behalf of the respondent no.4 it is submitted that, though no appeal

has been filed against the impugned order, the objection filed by them has

not been considered in accordance with the mandate of the Act.
3

7. Under section 53 of the Act, the term of any patent is 20 years from the

date of filing of an application for the patent. After expiry of the above

period any exclusivity attached to such patent ceases to exist and the

product or process becomes public property. Delay in such matters is not

only violative of the principles of natural justice but also makes a mockery

of the entire procedure for grant of patent. Significantly, despite the

change in the 2005 amendment being introduced to simplify and

rationalize the procedure for grant of patents so that the same could be

made more user friendly, delay in such matters cripples the objects of the

Act.

8. For convenience, the relevant dates summarizing the proceedings under

the Act are set out hereinbelow:

    Event                                             Date
    FIRST EXAMINATION REPORT
    PCT Application no. PCT/EP2006 /005869            19th June 2006
    International filing date
    India Filing Date                                 12th December 2007
    Publication under Section 11A                     2nd May 2008
    Request for examination filed on                  5th May 2009
    First examination report                          20th February 2012
    Response to First examination report              27th November 2012
    Respondent No. 2

Date of Opposition by Respondent No. 2. 22nd April, 2016
(Gujarat Insecticides Limited)
Reply Statement by Appellant 2nd September, 2016
Date of hearing in Pre grant Opposition filed 23rd March, 2017
by Respondent No. 2
Date of filing written submission by Appellant 10th April, 2017

Written Submissions by Respondent No. 2. 5th April, 2017
RESPONDENT NO. 3
Date of Opposition by Respondent No. 3 (GSP 15th November, 2018
Crop Science Pvt. Ltd.)
Reply Statement by Appellant. 7th November, 2019
Hearing date of Pre Grant-Opposition filed 2nd June, 2022
Date of filing written submission by Appellant. 16th July, 2022
Written Submissions by Respondent No. 3 15th June, 2022

Hearing under Section 14. 17th April ,2023
Date of Opposition by Respondent No. 4 1st March, 2024
Date of refusal under Section 15. 4th March 2024
4

9. A perusal of the above dates would reflect that there has been a travesty

of sorts in disposing of the subject application. The respondent

authorities have been sitting over the application till the 18th year of its

term. The delay is so obvious that the same can only be described as

deliberate and intentional. In particular, there has been delay caused by

the particular Hearing Officer at every stage of the proceeding which

would be evident from the fact that the response to the First Examination

Report was disposed of only after a period of four years. Thereafter,

despite the hearing having concluded on 31 March 2017, no order was

passed for more than a year. Subsequently, though the pre-grant

opposition had been filed and concluded on 2 June 2022, it was not until

17 April 2023 that the respondent issued a Hearing Notice under section

14 of the Act. Later, even after the hearing had been concluded on 17

April 2023 no order was passed until 4 March 2024. In view of the above,

on the ground of delay per se the impugned order is liable to be set aside

being in violation of the principles of natural justice.

10. The impugned order is also unsustainable on merits. In passing the

impugned order, the respondent no.1 failed to apply the well settled tests

to determine inventive steps. In Avery Dennison Corporation Vs. Controller

Of Patents and Designs (2022/DHC/004697), it has been held as follows:

Test for Inventive Step/Lack of Obviousness

10. In order to decide this issue, some of the fundamental principles for
determining the existence of an inventive step and the lack of obviousness
need to be emphasised.

11. For determining inventive step or lack thereof, various approaches and
tests have emerged over the years from decisions of courts/authorities as also
from examination guidelines of patent offices from different jurisdictions. The
same include:

5

i. Obvious to try approach:

• This approach involves an analysis of whether in view of the
teachings/solutions proposed in the prior art, it was obvious to try and arrive
at the subject invention.

ii. Problem/solution approach:

• This approach considers whether in the light of the closest prior art and the
objective technical problem, the solution claimed in the invention would be
obvious to the skilled person. If the skilled person can decipher the solution
being claimed, then the subject matter is held to be obvious.
• This test has been discussed by the Division Bench in F. Hoffmann-La Roche
Ltd. v. Cipla Ltd.
, (2016) 65 PTC 1 (Del).

iii. Could-Would Approach
• In this approach the question that is raised is whether there is any teaching
in the prior art as a whole that would and not simply could have prompted a
skilled person, with the knowledge of the objective technical problem, to either
modify or adapt the closest prior art to arrive at the subject matter of the
claims.

iv. Teaching Suggestion Motivation (TSM test)
• This test originated in the USA as per which, if by the Teaching, Suggestion
or Motivation from the prior art, an ordinary skilled person can modify the
prior art reference or combine prior art references to arrive at the claimed
invention, then the subject matter being claimed is obvious.
• However, the application of this test ought not to be done in a narrow
manner as held by the US Supreme Court in the case of KSR
International v. Teleflex, 550 US 398 (2007).

11. Similarly, in Groz-Beckert KG vs. Union of India and Others (2023 SCC

OnLine Cal 111), it has been held as follows:

7. Thus, in determining inventive steps, the invention should be
considered as a whole. In other words, it is not sufficient to draw the
conclusion that a claimed invention is obvious merely because
individual parts of the claim taken separately are known or might be
found to be obvious. The contention that an invention is obvious in
relation to a particular item must be treated with care and caution. In
doing so, the whole picture presented should be taken into
consideration and not a partial one. There should be an element of
preciseness about what is asserted to be common general knowledge.

The “obviousness” must also be strictly and objectively judged.

(Bishwanath Prasad Radhey Shyam v. Hindustan Metal
Industries
, (1979) 2 SCC 511 paras 24 & 25, F. Hoffman La Roche
Ltd. v. Cipla Ltd. PTC
1 paras 13, 143).

6

12. The impugned order is irreconcilable and inconsistent inasmuch as on

the one hand, the respondent no.1 has found that the invention is

obvious to a person skilled in the art and simultaneously concluded that

there was lack of inventive steps and insufficiency of disclosure. In such

circumstances, the entire basis of the impugned order to assess the

subject invention on the ground of inventive steps under section 2(1)(ja) of

the Act has been misapplied and is erroneous.

13. The conclusion that the subject invention was not patentable under

section 3(d) of the Act is also untenable. The impugned order does not

deal with any of the materials relied on by the appellant to sustain the

aspect of technical advantage of the subject invention. Significantly, the

impugned order does not deal with any of the documents being

A1(WO2004072039), A2(US3272706), A3 (Solvent Effect on Crystal

Polymorphism: Why Addition of Methanol or Ethanol To Aqueous Solutions

Induces the Precipitation of the Least Stable B Form of Glycine, Angewante

Chemie International Edition, Volume 44, Issue 21, pages 3226-3229, May

20, 2005), A7 (Journal of Structural Biology 142, page no.66-76, 2003) and

A8 (Organic Process Research and Development 2000, 4, 372-383) which

were relied on by the appellant to contend that there was technical

advancement in the subject invention and none of the above has been

adverted to in the impugned order. The impugned order is ex facie

erroneous in concluding that the subject invention failed in providing

therapeutic efficacy in comparison to crystalline Form-I by disregarding

the data which was submitted during the pendency of the application and

considered the subsequent developments. The comparative data to
7

establish inventive steps and section 3(d) demonstrating enhanced

fungicidal activity ought to have been dealt with in the impugned order

and has been ignored as a known substance with known efficacy of a

commercially available amorphous pyraclostrobin.

14. In Oyester Point Pharma Inc. vs. Controller of Patents and Designs and

Another, 2023 SCC OnLine Cal 2141 it has been held as follows:

12. Drug development is a lengthy and complex process. It may not be
possible to provide all data at the time of filing of the application. Further
screening may be required to be carried out before a prospective compound
ultimately makes it to clinical trials. Appendix C included the data which
showed the activity of the mono-citrate salt at different nAChR subtypes which
provides for structural and functional flexibility to play different roles and
enhance the efficacy of the compound. In fact, Appendix A, B, C contained
data to show that the claimed compound possesses efficacy. The Controller
has without assigning any reasons rejected Appendix C and has failed to deal
with Appendix A and Appendix B. The object of the present invention was to
obtain a stable salt for the preparation of a pharmaceutical formulation. The
stability data was provided in Appendix A which has not even been dealt with
nor considered in the impugned order.

15. The findings in the impugned order are also irreconcilable and

contradictory to the extent that on the one hand, the respondent no.1

alleged that the invention was obvious to a person skilled in the art and

on the other hand held that, based on documents A1, A2 and A3, the use

of the solvent and seeding techniques based on A7 and A8, the person

skilled in the art could clearly arrive at the process as claimed in claims 4

and 8. This finding is ex facie inconsistent. Lack of inventive step and

insufficiency of disclosure are antithesis to one another. In this context, it

has been observed that:

“We would add one further comment here: there is an interrelationship
between obviousness and insufficiency. At first blush one might
suppose that an idea which requires masses of work to implement
would be more readily rejected by, or less likely to occur to, the notional
8

unimaginative skilled person/team who is the addressee than one
which can be readily put into practice. This produces an apparent
paradox: the less sufficient the description, the less is an idea likely to
be obvious.” [Terrell On The Law Of Patents’ Sweet & Maxwell]

16. In Farbewerke Hoechst Aktiengesellschaft Vormals Meister Lucius &

Bruning a Corporation etc. Vs. unichem Laboratories & Ors. [AIR 1969 Bom

255] it has been held as follows:

“14. Dealing first with the ground of insufficiency of description it is stated in Halsbury, (3rd
edn.) Vol. 29, p. 64, para 131 that the claim need only be as clear as the subject admits, and that a
patentee need not so simplify his claim as to make it easy for infringers to evade it. It is further
stated in that passage in Halsbury that the patentee’s duty is not to prevent all possible argument
as to whether there is or is not infringement in particular cases, but to enable the Court to
formulate the questions of fact to be answered. It is further stated in the same volume of Halsbury
(p. 66, para 138) that insufficiency of description has two branches, (1) the complete specification
must describe “an embodiment” of the invention claimed in each of the claims, and that the
description must be sufficient to enable those in the industry concerned to carry it into effect
“without their making further inventions”; and (2) that the description must be fair i.e. it must not
be unnecessarily difficult to follow. Turning first to claim No. 11 in the present case in the light of
these principles, the reference in the body of the specification to “a conventional manner” of
eliminating sulphur cannot really create any difficulty, and it is in fact unnecessary to import this
from the body of the specification into claim No. 11 in view of the fact that claim No. 11 is
unambiguous and clear in terms, being wide enough to include all methods of eliminating sulphur.
As stated earlier in this judgment, it is permissible to refer to the body of the specification only
when there is some difficulty or ambiguity in the construction of a claim as it stands. In any event,
hydrogen peroxide as a desulphurising agent would be an obvious chemical equivalent of heavy
metal oxides or a salt thereof in an aqueous or alcoholic solution which are also used for
desulphurising in “a conventional manner”. Moreover, the secret or discovery essential to the
validity of the Plaintiffs’ invention as claimed and forming the very basis of it is not the method,
but is the previously undiscovered fact of a new class of chemical compounds having hitherto
unsuspected blood sugar lowering properties, twenty-one methods of synthesis of sulphonylureas
being already known at the material time as is apparent from p. 27 of Kurzer’s article on
sulphonylureas and sulphonylthioureas in Vol. 50 of the Chemical Review (exh. 1). There is no
evidence led by the defendants to show that the statement in the body of the specification that the
synthesis of the desired sulphonylurea may be obtained by eliminating sulphur with a heavy metal
oxide or a salt thereof in an aqueous or a alcoholic solution would present any difficulty. The
specification and claims are addressed to those with a high degree of knowledge of the field of
science to which they relate, particularly when they relate to chemistry and allied subjects. It is
not necessary to describe processes in the claims to a specification when they are part of the
common knowledge available to those skilled in the science who can, after reading them, refer to
the technical literature on the subject for the purpose of carrying them into effect. “An
embodiment” of the invention is, therefore, in my opinion, sufficiently described in the Plaintiffs’
patent and that description is not unnecessarily difficult to follow, it being sufficient to enable the
invention to be carried into effect “without…making further inventions.” As far as claim No. 1 is
concerned, there are as many as forty examples of it in the specification (exh. A) and there would,
therefore, be no difficulty in carrying the same into effect. The ground of insufficiency of
description alleged by the defendants must, therefore, fail.

9

17. In view of the above, the impugned order is unsustainable and set aside.

The appeal stands allowed. In view of the peculiar facts and

circumstances and the inordinate delay in disposing of the subject

application, the following directions are passed:

a. To issue a hearing notice within two weeks from the date of this
order and dispose of the subject application alongwith all
objections within four weeks from the date of communication of
this order;

b. As the documents filed by respondent no.4 in their objection are
the same and have been relied upon by respondent no.2, the
requirement for issuing notice under Rule 55(3) and the filing of
Reply Statement is dispensed with;

c. The appellant shall address the opposition filed by respondent no.4
at the hearing.

d. In order to obviate any apprehension of predetermination, the
Controller who has passed the impugned order shall not rehear the
matter and the subject application alongwith all the objections are
to be considered by any other Controller or Appropriate Officer.

18. With the above directions, IPDPTA/5/2024 stands allowed. It is made

clear that there has been no final adjudication on merits and all

questions are left open to be decided in accordance with law.

(Ravi Krishan Kapur, J.)



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here